Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dis-Chem PharmaciesJSE:DCP -0.67%87 Cyclically Adjusted PS Ratio is 0.74 as of Jul. 25, 2026, which is 21% below its 10-year median of 0.94. GuruFocus rates JSE:DCP with a GF Score™ of 87/100 and a GF Value™ of R38.30 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 357 Healthcare Providers & Services companies, Dis-Chem Pharmacies ranks better than 61.62% on this metric.
The historical rank and industry rank for Dis-Chem Pharmacies's Cyclically Adjusted PS Ratio or its related term are showing as below:
JSE:DCP'
s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.76 Med: 0.94 Max: 1.14
Current: 0.81
During the past 13 years, Dis-Chem Pharmacies's highest Cyclically Adjusted PS Ratio was 1.14. The lowest was 0.76. And the median was 0.94.
JSE:DCP's Cyclically Adjusted PS Ratio is ranked better than 61.62% of 357
companies
in the Healthcare Providers & Services industry
Industry Median: 1.13
vs JSE:DCP: 0.81
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.
Dis-Chem Pharmacies's adjusted revenue per share data of for the fiscal year that ended in Feb26 was R49.924. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is R39.99 for the trailing ten years ended in Feb26.
Shiller PE for Stocks: The True Measure of Stock Valuation
Dis-Chem Pharmacies (JSE:DCP) Cyclically Adjusted PS Ratio Explanation
Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.
Dis-Chem Pharmacies Cyclically Adjusted PS Ratio Related Terms
Dis-Chem Pharmacies Cyclically Adjusted PS Ratio Historical Data
* Premium members only.
The historical data trend for Dis-Chem Pharmacies's Cyclically Adjusted PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dis-Chem Pharmacies Cyclically Adjusted PS Ratio Chart
Dis-Chem Pharmacies Cyclically Adjusted PS Ratio Competitor Comparison
For the Pharmaceutical Retailers subindustry, Dis-Chem Pharmacies's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dis-Chem Pharmacies Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dis-Chem Pharmacies's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where Dis-Chem Pharmacies's Cyclically Adjusted PS Ratio falls into.
Dis-Chem Pharmacies Cyclically Adjusted PS Ratio Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.
Dis-Chem Pharmacies's Cyclically Adjusted PS Ratio for today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
What does a Cyclically Adjusted PS Ratio of 0.74 mean?
Dis-Chem Pharmacies (JSE:DCP) has a Cyclically Adjusted PS Ratio of 0.74 as of Jul. 25, 2026. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on Dis-Chem Pharmacies and its competitors. This is 21% below median its historical median of 0.94. Over the past decade, Dis-Chem Pharmacies' Cyclically Adjusted PS Ratio has ranged from 0.76 to 1.14. According to the industry distribution chart, Dis-Chem Pharmacies ranks #137 out of 357 companies in the Healthcare Providers & Services industry, placing it in the top 38.4%.
Is Dis-Chem Pharmacies' Cyclically Adjusted PS Ratio too high?
Dis-Chem Pharmacies' current Cyclically Adjusted PS Ratio of 0.74 is 21% below median its 10-year median of 0.94. Over the past 10 years, this metric has ranged from a low of 0.76 to a high of 1.14. The Healthcare Providers & Services industry median Cyclically Adjusted PS Ratio is 1.13. Dis-Chem Pharmacies' value of 0.74 is 34.5% below this industry median. Based on the distribution chart, Dis-Chem Pharmacies ranks #137 out of 357 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Dis-Chem Pharmacies has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dis-Chem Pharmacies' Cyclically Adjusted PS Ratio compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Dis-Chem Pharmacies ranks #137 out of 357 companies for Cyclically Adjusted PS Ratio. This puts Dis-Chem Pharmacies in the upper half of its industry. The industry median Cyclically Adjusted PS Ratio is 1.13. Dis-Chem Pharmacies' value of 0.74 is 34.5% below this benchmark. Historically, Dis-Chem Pharmacies' own Cyclically Adjusted PS Ratio has ranged from 0.76 to 1.14 over the past decade. While the company's 10-year median is 0.94 vs. the industry median of 1.13, Dis-Chem Pharmacies has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PS Ratio for a Healthcare Providers & Services company?
The median Cyclically Adjusted PS Ratio among Healthcare Providers & Services companies is 1.13, based on 357 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dis-Chem Pharmacies's current Cyclically Adjusted PS Ratio of 0.74 is 34.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PS Ratio mean?
A high Cyclically Adjusted PS Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on Dis-Chem Pharmacies and its competitors. For the Healthcare Providers & Services industry, the median Cyclically Adjusted PS Ratio is 1.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dis-Chem Pharmacies's current Cyclically Adjusted PS Ratio is 0.74, which is 21% below median its own 10-year median of 0.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dis-Chem Pharmacies stock overvalued right now?
Based on GuruFocus' analysis, Dis-Chem Pharmacies (JSE:DCP) is currently considered Modestly Undervalued. The stock's GF Value™ is R38.30, compared to a current price of R29.65 — trading 22.6% below its estimated fair value. The current Cyclically Adjusted PS Ratio is 0.74, which is 21% below median its 10-year median of 0.94 and 34.5% below the Healthcare Providers & Services industry median of 1.13. Dis-Chem Pharmacies' overall GF Score™ is 87/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PS Ratio calculated?
Cyclically Adjusted PS Ratio is calculated from a company's financial statements. For Dis-Chem Pharmacies (JSE:DCP), the current Cyclically Adjusted PS Ratio is 0.74 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dis-Chem Pharmacies (JSE:DCP) Overvalued in 2026?
Based on GuruFocus' analysis, Dis-Chem Pharmacies stock appears to be undervalued.
The current stock price of R29.65 is trading 22.6% below its estimated GF Value™ of R38.30.
GuruFocus considers Dis-Chem Pharmacies to be Modestly Undervalued.
Key valuation signals for JSE:DCP:
Cyclically Adjusted PS Ratio: 0.74 (21% below median its 10-year median of 0.94)
GF Value™: R38.30 vs. price of R29.65 (22.6% below fair value)
Industry Position: 34.5% below the Healthcare Providers & Services median (#137 of 357)
No single metric tells the full story. See the JSE:DCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dis-Chem Pharmacies Ltd is a pharmaceutical company based in South Africa. Its product portfolio includes personal care products, beauty products, healthcare and nutrition products, and dispensary and baby care products. The operating segments of the group are Retail and Wholesale. It derives maximum revenue from the Retail segment, which includes company stores, retailers of pharmaceuticals and a variety of health and beauty products, as well as pharma-logistic services and oncology and retailers of pharmaceutical products. The Wholesale segment consists of the CJ wholesale and company distribution businesses, wholesalers of pharmaceuticals, and a variety of health and beauty products. Geographically, the group carries out its business operations principally in South Africa.
87GF Score
Get the complete analysis for JSE:DCP
Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:DCP has been successfully added to your 
